This year at the 2024 Variant Effect Prediction Training Course (VEPTC), QIAGEN will be showcasing our industry-leading next-generation sequencing (NGS) variant analysis, interpretation and reporting solutions. Trusted to analyze and interpret more than 4 million NGS patient test cases, QIAGEN Clinical Insight (QCI) is the industry’s leading clinical decision support platform by volume. Find out why nobody does variant analysis and interpretation better than QIAGEN at VEPTC 2024.
Learn more and schedule a VIP meeting with our experts at VEPTC 2024 here.
